• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有AL型心脏淀粉样变性和快速进展性心力衰竭的患者错失抗凝治疗时机。

Missed opportunity for anticoagulation in a patient with AL cardiac amyloidosis and rapidly progressive heart failure.

作者信息

Avula Sindhu Reddy, Handa Rishin, Balakrishnan Bathmapriya, Girard Steven

机构信息

Department of Internal Medicine, Saint Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, USA.

Department of Cardiovascular Medicine, Saint Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, USA.

出版信息

BMJ Case Rep. 2017 Aug 7;2017:bcr-2017-220538. doi: 10.1136/bcr-2017-220538.

DOI:10.1136/bcr-2017-220538
PMID:28784887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5623239/
Abstract

A previously healthy 65-year-old woman presented with progressive symptoms of heart failure. Low-voltage ECG and findings on echocardiography were concerning for infiltrative cardiomyopathy. Cardiac MRI showed biventricular late gadolinium enhancement, and endomyocardial biopsy confirmed monoclonal immunoglobulin light-chain (AL) amyloidosis. Bortezomib-based chemotherapy was initiated, but the patient continued to clinically deteriorate. She required hospital readmission after resuscitated out-of-hospital cardiac arrest attributed to progressive conduction disease, and a permanent pacemaker was implanted. Chest CT angiography showed a small subsegmental pulmonary embolism (PE), but anticoagulation was withheld as her lower extremity Doppler was negative. One month later, another pulseless electrical arrest occurred, due to massive PE. Thereafter, she had refractory class IV congestive heart failure with severe right ventricular dysfunction, and was deemed unsuitable for stem-cell or heart transplantation. This case highlights the predilection for thromboembolism in AL cardiac amyloidosis.

摘要

一名65岁既往健康的女性出现进行性心力衰竭症状。心电图低电压及超声心动图检查结果提示浸润性心肌病。心脏磁共振成像显示双心室晚期钆增强,心内膜活检确诊为单克隆免疫球蛋白轻链(AL)淀粉样变性。开始基于硼替佐米的化疗,但患者临床症状持续恶化。因进行性传导疾病导致院外心脏骤停复苏后,她需要再次入院,并植入了永久性起搏器。胸部CT血管造影显示有一个小的亚段肺栓塞(PE),但由于下肢多普勒检查阴性,未进行抗凝治疗。1个月后,因大面积肺栓塞发生了另一次无脉电活动骤停。此后,她出现难治性IV级充血性心力衰竭伴严重右心室功能障碍,被认为不适合进行干细胞或心脏移植。该病例突出了AL型心脏淀粉样变性中血栓栓塞的倾向。

相似文献

1
Missed opportunity for anticoagulation in a patient with AL cardiac amyloidosis and rapidly progressive heart failure.一名患有AL型心脏淀粉样变性和快速进展性心力衰竭的患者错失抗凝治疗时机。
BMJ Case Rep. 2017 Aug 7;2017:bcr-2017-220538. doi: 10.1136/bcr-2017-220538.
2
Long-Term Electrocardiographic Follow-Up of a Patient with Light-Chain Cardiac Amyloidosis.轻链心脏淀粉样变性患者的长期心电图随访。
J Nippon Med Sch. 2022 Mar 11;89(1):119-125. doi: 10.1272/jnms.JNMS.2022_89-111. Epub 2021 Mar 9.
3
Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.与肥厚型心肌病相关的轻链淀粉样变导致难治性心力衰竭的突然发作。
JAMA Cardiol. 2017 Jan 1;2(1):94-97. doi: 10.1001/jamacardio.2016.3894.
4
An interesting case of AL amyloidosis and MM: a complex scenario with cardiac involvement.一例有趣的AL淀粉样变性和多发性骨髓瘤病例:伴有心脏受累的复杂情况。
BMJ Case Rep. 2024 Jan 24;17(1):e256012. doi: 10.1136/bcr-2023-256012.
5
Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.体外膜肺氧合作为系统性轻链淀粉样变性所致急性心力衰竭的决策桥梁。
Am J Case Rep. 2015 Mar 24;16:174-81. doi: 10.12659/AJCR.892772.
6
Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.严重心力衰竭的免疫球蛋白轻链淀粉样变性患者的预后评估:右心室功能的预测价值
Heart Vessels. 2020 Apr;35(4):521-530. doi: 10.1007/s00380-019-01513-y. Epub 2019 Sep 26.
7
Strange case of biventricular heart failure.双心室心力衰竭的疑难病例。
BMJ Case Rep. 2021 Jan 18;14(1):e239658. doi: 10.1136/bcr-2020-239658.
8
Mechanisms of heart failure in transthyretin vs. light chain amyloidosis.转甲状腺素蛋白与轻链淀粉样变性性心力衰竭的发病机制。
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):512-524. doi: 10.1093/ehjci/jey225.
9
Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.达雷妥尤单抗、泊马度胺和地塞米松作为系统性轻链淀粉样变伴晚期心脏受累患者自体干细胞移植的桥接治疗。
J Oncol Pharm Pract. 2019 Jun;25(4):1021-1025. doi: 10.1177/1078155218815305. Epub 2018 Nov 26.
10
Conventional cardiopulmonary resuscitation-induced refractory cardiac arrest due to latent left ventricular outflow tract obstruction due to a sigmoid septum: a case report.乙状结肠隔导致潜在左心室流出道梗阻引发传统心肺复苏术所致难治性心脏骤停:一例报告
J Med Case Rep. 2018 Aug 20;12(1):229. doi: 10.1186/s13256-018-1767-z.

引用本文的文献

1
Pleural amyloidosis with recurrent pleural effusion and pulmonary embolism: A case report.伴有反复胸腔积液和肺栓塞的胸膜淀粉样变性:一例报告
Medicine (Baltimore). 2019 Jan;98(3):e14151. doi: 10.1097/MD.0000000000014151.

本文引用的文献

1
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.抗栓治疗 VTE 疾病:CHEST 指南和专家小组报告。
Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.
2
Natural history and therapy of AL cardiac amyloidosis.AL型心脏淀粉样变性的自然病史与治疗
Heart Fail Rev. 2015 Mar;20(2):155-62. doi: 10.1007/s10741-014-9464-5.
3
Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.高剂量美法仑和自体造血干细胞移植在伴有心脏受累的 AL 淀粉样变性患者中的安全性和疗效。
Bone Marrow Transplant. 2014 Mar;49(3):434-9. doi: 10.1038/bmt.2013.192. Epub 2013 Dec 9.
4
Implantable cardioverter defibrillators in patients with cardiac amyloidosis.心脏淀粉样变患者的植入式心脏复律除颤器。
J Cardiovasc Electrophysiol. 2013 Jul;24(7):793-8. doi: 10.1111/jce.12123. Epub 2013 Mar 14.
5
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis.在淀粉样变性患者中,通过优化患者选择以降低自体干细胞移植治疗相关死亡率。
Bone Marrow Transplant. 2013 Apr;48(4):557-61. doi: 10.1038/bmt.2012.170. Epub 2012 Sep 10.
6
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure.伴有肾衰竭的淀粉样变心脏生物标志物的最佳应用。
Am J Hematol. 2012 May;87(5):465-71. doi: 10.1002/ajh.23141. Epub 2012 Mar 3.
7
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.肾病综合征相关血栓栓塞疾病的流行病学和病理生理学。
Clin J Am Soc Nephrol. 2012 Mar;7(3):513-20. doi: 10.2215/CJN.10131011. Epub 2012 Feb 16.
8
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.改良的轻链淀粉样变预后分期系统,纳入了心脏生物标志物和血清游离轻链检测。
J Clin Oncol. 2012 Mar 20;30(9):989-95. doi: 10.1200/JCO.2011.38.5724. Epub 2012 Feb 13.
9
How to manage primary amyloidosis.原发性淀粉样变的治疗方法。
Leukemia. 2012 Feb;26(2):191-8. doi: 10.1038/leu.2011.219. Epub 2011 Aug 26.
10
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.原发性系统性淀粉样变生存状况的近期改善和早期死亡率风险评分的重要性。
Mayo Clin Proc. 2011 Jan;86(1):12-8. doi: 10.4065/mcp.2010.0480.